Literature DB >> 15500822

Indocyanine green enhanced retinal vessel laser closure in rats: histologic and immunohistochemical observations.

Jeremy D Wolfe1, Karl G Csaky.   

Abstract

PURPOSE: Feeder vessel photocoagulation using both thermal and indocyanine green (ICG) enhanced applications as a treatment for choroidal neovascularization is under investigation. While closure of feeder vessels is achievable, reperfusion of these vessels occurs. The purpose of the following study was to compare, contrast anatomic, and immunohistochemical findings in rat retinal arterioles following attempts at vessel closure using either the diode (810 nm) laser alone or in conjunction with intravascular ICG.
METHODS: The retinal arterioles of adult Lewis or Brown Norway rats were treated with diode laser alone or immediately following intravenous injection with 75 mg ml(-1) ICG. Retinal vessel closure was determined by examination of retinal flatmounts following FITC-dextran or rhodamine-dextran perfusion. Anatomic changes were examined by electron microscopy and quantitative cellular changes were measured by perfusion with Hoechst 33342 nuclear staining. Recruited macrophages were detected by ED1 immunohistochemistry.
RESULTS: Treatment with diode laser alone resulted in partial retinal arteriolar closure seen only in pigmented animals. The use of adjuvant ICG achieved complete vessel closure in albino animals with reperfusion seen in all vessels by 7 days. Electron microscopy revealed an intraluminal clot only in ICG-enhanced diode laser treated animals, but with accompanying endothelial and perivascular cellular damage. Immunohistochemistry of the site of retinal arteriolar closure revealed a large increase in perivascular cellularity with an apparent influx of ED1 positive cells.
CONCLUSION: ICG-enhanced diode laser photocoagulation appears to be superior to diode treatment alone in achieving vessel closure, but is limited by clot resolution due to both excessive vascular damage and an accompanying inflammatory response. These results suggest that more durable feeder vessel closure rates may be achievable with either the use of accompanying anti-inflammatory therapies or with a less vascular damaging photoactivating dye.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500822     DOI: 10.1016/j.exer.2004.05.018

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  5 in total

1.  Indocyanine green enhanced near-infrared laser treatment of murine mammary carcinoma.

Authors:  Gal Shafirstein; Wolfgang Bäumler; Leah J Hennings; Eric R Siegel; Ran Friedman; Mauricio A Moreno; Jessica Webber; Cassie Jackson; Robert J Griffin
Journal:  Int J Cancer       Date:  2011-07-21       Impact factor: 7.396

2.  Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration.

Authors:  I Kozak; L Cheng; D E Cochran; W R Freeman
Journal:  Br J Ophthalmol       Date:  2006-06-14       Impact factor: 4.638

3.  Hyperthermia-enhanced indocyanine green delivery for laser-induced thermal ablation of carcinomas.

Authors:  Klressa D Barnes; Gal Shafirstein; Jessica S Webber; Nathan A Koonce; Zachary Harris; Robert J Griffin
Journal:  Int J Hyperthermia       Date:  2013-08       Impact factor: 3.914

4.  Self-assembly synthesis, tumor cell targeting, and photothermal capabilities of antibody-coated indocyanine green nanocapsules.

Authors:  Jie Yu; David Javier; Mohammad A Yaseen; Nitin Nitin; Rebecca Richards-Kortum; Bahman Anvari; Michael S Wong
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

5.  Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy.

Authors:  Zhenzhen Tu; Yuxiang Ma; Walter Akers; Samuel Achilefu; Yueqing Gu
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-15       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.